MTS Medication Technologies

St. Petersburg, United States Founded: 1984 • Age: 42 yrs Acquired By Omnicell
Developer of automated medication dispensing machine
Request Access

About MTS Medication Technologies

MTS Medication Technologies is a company based in St. Petersburg (United States) founded in 1984 was acquired by Omnicell in May 2012.. MTS Medication Technologies has raised $13 million across 1 funding round from investors including Omnicell, Bank of America and Berwind. MTS Medication Technologies operates in a competitive market with competitors including Parata Systems, NewIcon, Rowa, Med Management and Centred Solutions, among others.

  • Headquarter St. Petersburg, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Mts Medication Technologies, Inc
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $13 M (USD)

    in 1 rounds

  • Latest Funding Round
    $13 M (USD), Series B

    Jun 01, 2004

  • Investors
    Omnicell

    & 3 more

  • Employee Count
    Employee Count
  • Acquired by
    Omnicell

    & 1 more

    (May 02, 2012)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of MTS Medication Technologies

MTS Medication Technologies has successfully raised a total of $13M through 1 strategic funding round. The most recent funding activity was a Series B round of $13 million completed in June 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series B — $13.0M
  • First Round

    (01 Jun 2004)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2004 Amount Series B - MTS Medication Technologies Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in MTS Medication Technologies

MTS Medication Technologies has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Omnicell, Bank of America and Berwind. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Berwind is operated as a family-owned investment management company.
Founded Year Domain Location
Excellere Partners is engaged in private equity investments.
Founded Year Domain Location
Commercial banking and asset management services are offered worldwide.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by MTS Medication Technologies

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - MTS Medication Technologies

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Mts Medication Technologies Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of MTS Medication Technologies

MTS Medication Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parata Systems, NewIcon, Rowa, Med Management and Centred Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Automated pharmacy dispensing and adherence packaging solutions are provided.
domain founded_year HQ Location
Pharmacy automation storage solutions are provided for hospitals and pharmacies.
domain founded_year HQ Location
Automated pharmacy dispensing robots are developed for efficient medicine handling.
domain founded_year HQ Location
Online platform for compliance aid and pharmacy automation
domain founded_year HQ Location
Offers software and technology for automated pharmacy dispensing workflows globally.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mts Medication Technologies

Frequently Asked Questions about MTS Medication Technologies

When was MTS Medication Technologies founded?

MTS Medication Technologies was founded in 1984 and raised its 1st funding round 20 years after it was founded.

Where is MTS Medication Technologies located?

MTS Medication Technologies is headquartered in St. Petersburg, United States. It is registered at St. Petersburg, Florida, United States.

Is MTS Medication Technologies a funded company?

MTS Medication Technologies is a funded company, having raised a total of $13M across 1 funding round to date. The company's 1st funding round was a Series B of $13M, raised on Jun 01, 2004.

What does MTS Medication Technologies do?

MTS Medication Technologies (acquired by Omnicell) has developed medication adherence packaging systems. The system enables the pharmacies to manage medication dispensing and administration. The company has developed automated packaging machinery and consumables.

Who are the top competitors of MTS Medication Technologies?

MTS Medication Technologies's top competitors include Parata Systems, Synergy Medical and NewIcon.

Who are MTS Medication Technologies's investors?

MTS Medication Technologies has 4 investors. Key investors include Omnicell, Bank of America, Berwind, and Excellere Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available